Berry Haze merges two of the most influential genetic families in modern cannabis: the sweet-fruit indica foundation of DJ Short’s Blueberry and the cerebral, terpene-rich architecture of equatorial Haze landraces (combining Mexican, Colombian, Thai, and South Indian stock). Bred to temper the extended flowering cycle of heritage Haze cultivars while introducing rich berry esters and balanced calyx density, Berry Haze offers steady daytime symptom control paired with gentle physical relaxation.

Cultivated indoors within advanced European pharmaceutical facilities operating under GACP methodologies, environmental factors such as light spectra, temperature swings, and relative humidity are controlled to maximize glandular trichome retention and monoterpene preservation. Across European medical cannabis frameworks—particularly Germany under the CanG framework, the United Kingdom, and Poland—Berry Haze is widely prescribed for chronic depressive symptoms, daytime pain management, fatigue, and neurological spasticity.

Technical Specifications & Certificate of Analysis (CoA)

Sensory & Terpene Profile Breakdown

• Sweet Wild Berries & Floral Jam: Dominated by a pronounced concentration of Myrcene and secondary fruit esters derived from the Blueberry parent, providing an aroma of fresh blackberries, blue fruit, and floral nectar.

• Spicy Incense & Sandalwood Haze: The classic Haze lineage contributes an earthy, resinous incense, dry cedarwood, and delicate black pepper base anchored by Beta-Caryophyllene.

• Crisp Pine & Citric Freshness: Alpha-Pinene and trace Terpinolene introduce an herbal freshness on inhalation, clearing the palate and enhancing respiratory smoothness.

• Visual Morphology: Tightly structured, spear-shaped bright forest-green colas displaying lavender and soft violet undertones, woven with fine copper pistils and a crystalline frost of stalked glandular trichomes.

European Compliance, Quality Assurance & Distribution

• EU-GMP Quality Assurance: Cured, trimmed, and packaged in certified pharmaceutical cleanrooms under EU-GMP parameters, ensuring lot-to-lot homogeneity, physical integrity, and zero chemical adulteration.

• Accredited Laboratory Testing: Fully analyzed by third-party ISO/IEC 17025 accredited laboratories in alignment with Ph. Eur. Chapter 5.1.8, certifying compliance regarding the absence of heavy metals (lead, arsenic, cadmium, mercury), agrochemical residues, aflatoxins, and microbial pathogens.

• Schengen Cross-Border Logistics: Supported by a complete regulatory documentation suite, including batch-specific Certificates of Analysis (CoAs), Active Pharmaceutical Ingredient (API) dossiers, and authorized bilateral narcotics import/export permits for commercial transit across European member states.

• Medical Packaging Integrity: Sealed in light-blocking, child-resistant, nitrogen-flushed pharmaceutical pouches or medical-grade amber PET jars equipped with integrated 62% humidity regulators to prevent volatile monoterpene evaporation and maintain target moisture levels during transit.